鹿血晶预防非小细胞肺癌患者化疗后白细胞减少症的临床效果

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (0 KB) HTML (36 KB)
Export: BibTeX | EndNote (RIS)

Abstract ObjectiveTo observe the influence of Deer Blood Crystal on the curative effect and quality of life of leukopenia in patients with NSCLC after chemotherapy.Methods80 cases with NSCLC treated firstly by the envelope method from January 2015 to December 2016 were randomly divided into study group and control group,and there were 40 cases in each group.The study group was treated with GP chemotherapy combined with Deer Blood Crystal treatment while the control group was not given Deer Blood Crystal during GP chemotherapy.The change of white blood cell,the usage dose of rhG-CSF,quality of life score and adverse reactions in the two groups were observed.ResultsThere were 8 cases (20.0%)withⅢ～Ⅳ grade leucopenia in the study group which was lower than that of the control group[11 cases (27.5%)],but the difference was not statistically significant(P＞0.05).The duration time of leukopenia after chemotherapy in the study group was shorter compared with the control group,but the difference was not statistically significant(P＞0.05).The usage dose of rhG-CSF in the study group was significantly reduced compared with the control group,and the difference of more than 5 branches was statistically significant(P＜0.05).The quality of life score in the study group score was higher than that of the control group,and the difference was statistically significant(P＜0.05).There was no significant difference in the incidence rate of adverse reactions such as thrombocytopenia,hemoglobin reduction,abnormal liver and kidney function,phlebitis and electrocardiogram change in the study group and the control group(P＞0.05).ConclusionDeer Blood Crystal can prevent the occurrence of leucopenia in patients with NSCLC after chemotherapy,improve the quality of life,but it also needs to be expanded the cases for further clinical research to confirm.

Key words： Deer Blood Crystal NSCLC Chemotherapy Leukopenia

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZENG Chun-sheng
	XU Qing-yun
	GUO Shou-jun
	YI Yan-fei

Cite this article:

ZENG Chun-sheng,XU Qing-yun,GUO Shou-jun, et al. The clinical effect of Deer Blood Crystal preventing leucopenia of patients with NSCLC after chemotherapy[J]. 中国当代医药, 2017, 24(23): 55-57.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2017/V24/I23/55

[1]	Anglim PP，Alonzo TA，Laird-Offringa IA.DNA methylationbased biomarkers for early detection of non-small cell lung cancer：an update[J].Mol Cancer，2008，7（1）：81.
[2]	汤森路透，史志祥，吕蒙莹.聚焦非小细胞肺癌：个体化治疗的新时代[J].药学进展，2014，38（3）：231-240.
[3]	汪晓洁，寿涛，胡静，等.不同剂量rhG-CSF预防晚期非小细胞肺癌化疗后白细胞减少的临床研究[J].中国癌症杂志，2015，25（10）：823-827.
[4]	许淼，陈光.吉西他滨联合顺铂治疗老年非小细胞肺癌的临床观察[J].中国老年学杂志，2011，31（9）：1651-1652.
[5]	张志颉，孙佳明，牛晓晖，等.鹿血化学成分及其药理作用研究[J].吉林中医药，2013，33（1）：61-63.
[6]	张之南.血液病诊断及疗效标准[M].北京：科学出版社，1998.
[7]	周际昌.实用肿瘤内科学[M].北京：人民卫生出版社，2003.
[8]	刘大为，陈兴华，谢晓冬，等.参附注射液改善乳腺癌患者化疗后生活质量的临床研究[J].中国当代医药，2009，16（7）：81-82.
[9]	张奇兵，袁珺，刘伦波，等.肺癌患者化疗后骨髓抑制45例分析[J].中国医院用药评价与分析，2015，15（12）：1662-1664.
[10]	高广辉，周鑫莉，黄若凡，等.铂类联合吉西他滨或长春瑞滨治疗晚期非小细胞肺癌的Meta分析[J].中国肺癌杂志，2009，12（1）：38-43.
[11]	徐校成，吕颖颖，徐佳灵.晚期非小细胞肺癌患者化疗对免疫功能的影响[J].中华医院感染学杂志，2015，25（6）：1312-1314.
[12]	蒋蕾，赵文静，常惟智.鹿血的药理作用及临床应用概况[J].中医药信息，2006，23（6）：12-13.
[13]	袁相恋，薄士儒，李庆杰，等.鹿血化学成分和药理作用及其应用研究进展[J].经济动物学报，2011，15（4）：207-211.
[14]	何晓华，李占林.非小细胞肺癌的中医药治疗概况[J].环球中医药，2015，8（5）：613-616.
[15]	田晓艳，刘延吉，张弘.马鹿血浆活性物质的研究现状及展望[J].中医药信息，2010，27（3）：117-119.